Biomedal
Biomedal is a Sevilla-based Spanish biotech company that develops patented GIP-detection diagnostics for celiac disease management (iVYDAL), ISO-accredited food safety testing, and custom life science research services. It serves clinical labs, celiac patients, food manufacturers, and biotech researchers.
- Company typePrivate
- Founded2000
- HeadquartersSevilla, Spain
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Biomedal does
Biomedal, S.L. is a privately held Spanish biotechnology company headquartered in Sevilla with laboratory and production facilities in Camas, operating across three divisions: in vitro diagnostics (iVYDAL), food and beverage analytical services, and life science research services. Its core technology is the detection of Gluten Immunogenic Peptides (GIP) using patented monoclonal antibodies G12 and A1, developed jointly with the University of Seville. The iVYDAL division offers professional-use products including the iVYLISA GIP Stool quantitative ELISA and iVYCHECK GIP Stool/Urine rapid immunochromatographic tests, plus the GlutenDetect home testing line sold direct-to-consumer and the GlutenPack standardized gluten sachets for clinical use.
The company generates revenue through one-time product sales of IVD kits to clinical laboratories and consumers, fee-for-service analytical testing for the agri-food industry (allergens, microbiological, physico-chemical), and custom biotechnology services (gene synthesis, recombinant protein expression across five systems, custom peptide synthesis, antibody production, and bioinformatics). Distribution is hybrid: direct B2B sales for professional diagnostics and lab services, and own e-commerce storefronts for consumer and life science services. Quality infrastructure is anchored by ISO 17025, ISO 9001, and ISO 13485 certifications across divisions, with reference laboratory status from FACE and ADILAC providing institutional credibility in the Spanish celiac and lactose-intolerance communities.
Financially, Biomedal is self-funded: no external VC or PE investment is evidenced. The company has received non-dilutive EU FEDER grants (~€251K in 2020 for COVID-related diagnostics and facility expansion, plus REACT-UE energy support) and participates in the ICEX Next internationalization program. In April 2025, Biomedal executed a partial spin-off, transferring real estate and asset management activities to a newly created BIGFAIVICS INVESTMENTS, S.L., leaving the biotech operating company leaner and more focused. The company currently lists Spain as its only served market and employs 11-50 people.
Biomedal firmographics
Firmographics- Name
- Biomedal
- Legal name
- BIOMEDAL, S.L.
- Website
- https://biomedal.com/
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biomedal is a Sevilla-based Spanish biotech company that develops patented GIP-detection diagnostics for celiac disease management (iVYDAL), ISO-accredited food safety testing, and custom life science research services. It serves clinical labs, celiac patients, food manufacturers, and biotech researchers.
- Ownership category
- akta.pro rank
Biomedal industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
- akta.pro secondary industries
- Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
Keywords
Where Biomedal is headquartered
LocationHeadquarters
- HQ city
- Sevilla
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
Biomedal business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- In Vitro Diagnostic Products: Sale of professional-use and home-use diagnostic tests for celiac disease monitoring. Products include iVYLISA GIP Stool (96-well ELISA kit), iVYCHECK GIP Stool and Urine rapid tests, and GlutenDetect home testing kits. Revenue generated through direct product sales to healthcare professionals and consumers.
- Analytical Laboratory Services: Food and beverage analysis services for the agri-food industry including allergen analysis, microbiological testing, physico-chemical analysis, and other specialized food testing. Services offered to food manufacturers and the agri-food sector with emergency 24-hour turnaround available.
- Life Science Research Services: Biotechnology services including genetic engineering (gene synthesis, oligo synthesis, sequencing), expression and purification of recombinant proteins, custom peptide synthesis, antibody production, and bioinformatics analysis. Services targeted at life sciences researchers and the biotechnology industry.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Biomedal product offering
Product offeringCore offering
Biomedal is a biotechnology company that develops, manufactures, and commercializes in vitro diagnostic kits and laboratory services. Its flagship offering is the only non-invasive Gluten Immunogenic Peptides (GIP) detection technology for monitoring gluten-free diet adherence in celiac patients, using proprietary G12 and A1 monoclonal antibodies in ELISA and lateral flow formats. The company also operates ISO 17025-accredited food analytical laboratories and provides life science research services including gene synthesis, recombinant protein expression, peptide synthesis, and antibody production.
Product overview
Biomedal is a biotechnology company with a multi-divisional structure offering in vitro diagnostic products, analytical laboratory services, and life science services. The iVYDAL In Vitro Diagnostics division provides professional-use celiac disease management tools including iVYLISA GIP Stool (quantitative ELISA), iVYCHECK GIP Stool and iVYCHECK GIP Urine (rapid immunochromatographic tests), and GlutenPack (professional gluten sachets). The home testing division offers GlutenDetect Stool and Urine tests for patient self-monitoring of gluten-free diet compliance. The Analytical Services division provides ISO 17025 accredited food testing including allergen analysis, microbiological analysis, physico-chemical analysis, and COVID-19 surface detection. The Life Science division offers genetic engineering services (gene synthesis, oligo synthesis, sequencing), recombinant protein expression in five systems (E. coli, B. subtilis, yeast, baculovirus, mammalian cells), custom peptide synthesis, antibody production (polyclonal, monoclonal, phage libraries), and bioinformatics analysis.
Differentiator
Problem solved
Functional benefit
Brands
- iVYDAL In Vitro Diagnostics: In vitro diagnostic products for the diagnosis and management of celiac disease, including tests for detecting Gluten Immunogenic Peptides (GIP) in stool and urine samples
- iVYLISA GIP Stool
- iVYCHECK GIP Stool
- iVYCHECK GIP Urine
- GlutenDetect
- GlutenPack
- Biomedal Life Science
- Biomedal Servicios Analíticos
Products and services
- iVYLISA GIP Stool Quantitative Sandwich ELISA test for detection and quantification of Gluten Immunogenic Peptides (GIP) in stool samples. Uses G12 monoclonal antibody against the 33-mer peptide. For professional use in clinical analysis laboratories. 96-well format (catalog KT-5739).
- iVYCHECK GIP Stool Rapid immunochromatographic lateral flow test for qualitative detection of Gluten Immunogenic Peptides (GIP) in stool samples. Results in 15-30 minutes as red line (positive) or green control line. For professional use. Available in 25-test and 10-test formats.
- iVYCHECK GIP Urine Rapid immunochromatographic test for qualitative detection of Gluten Immunogenic Peptides (GIP) in urine samples. Urine sample mixed with Conditioning Solution before detection. For professional use by doctors, pharmacists, or specialists. Available in 25-test and 10-test formats.
- GlutenDetect Stool Test Rapid home test for detection of Gluten Immunogenic Peptides (GIP) in stool samples. Lateral flow strip similar to a pregnancy test format. Enables self-monitoring of gluten-free diet at home without visiting a medical center. Results in 15-30 minutes. 2-test format.
- GlutenDetect Urine Test Rapid home test for detection of Gluten Immunogenic Peptides (GIP) in urine samples. Lateral flow strip format for self-monitoring gluten-free diet adherence at home. Results in 15-30 minutes. Available in 1-test, 5-test, and 12-test formats.
- GlutenPack Individual 11g gluten sachets packaged in 30-unit packs. Designed for hospital environments, research centers, and laboratories requiring precision, convenience, and standardization in gluten handling. Available exclusively for professional use.
- Food Allergen Analysis Analytical service for detection of food allergens including gluten, milk proteins, nuts, egg, sulfites, and others. Performed at an ISO/IEC 17025 accredited laboratory that serves as a reference laboratory for FACE (Federation of Celiac Associations of Spain) and ADILAC (Association of Lactose Intolerant Spain).
- Microbiological Analysis Microbiological testing services for food including Salmonella, Listeria, and other pathogens, plus surface microbiology and water analysis. Emergency 24-hour turnaround available.
- Physico-chemical Analysis Physical-chemical analysis services for food and water including nutritional analysis, organoleptic testing, fatty acids, vitamins, heavy metals, sulfites, acidity, and phosphates.
- COVID-19 Detection on Surfaces PCR-based detection service for COVID-19 virus on surfaces. Designed to verify effectiveness of disinfection and cleaning protocols. Provides early detection with high specificity and sensitivity.
- Gene Synthesis De novo gene synthesis service producing double-stranded DNA genes up to 3,000 bp. Includes codon optimization, sequencing verification, and delivery of approximately 4 µg lyophilized DNA cloned into a vector. Efficiency greater than 99.9%.
- Oligo Synthesis Oligonucleotide synthesis service. DNA oligos from 12-140 bases, RNA oligos from 2-40 bases. Multiple purification methods (RP-cartridge, HPLC, PAGE). Quality controlled by MALDI mass spectrometry. Various modifications available for 5', 3', and internal positions.
- Sequencing Service DNA sequencing services including Sanger sequencing and Next-Generation Sequencing (NGS). NGS platforms include Ion Torrent, Illumina HiSeq 2500, and MiSeq. Results in 48 hours for Sanger sequencing.
- Recombinant Protein Expression and Purification Recombinant protein production service with five expression systems: E. coli, B. subtilis, yeast (P. pastoris, S. cerevisiae), baculovirus (Sf9, Sf21, Hi5), and mammalian cells (HEK, CHO). Capacity up to 24 L in flasks and over 100 L in bioreactors.
- Custom Peptide Synthesis Custom peptide synthesis service with no size limit in amino acid sequence, with all types of modifications available, guaranteed purity with HPLC and MS verification, COA documentation, 5-week delivery, and a 99% success rate. Backed by over 17 years of experience.
- Antibody Production Comprehensive antibody production services including polyclonal antibodies (rabbit, mouse, rat, chicken, goat, sheep, llama, alpaca) and monoclonal antibodies via hybridoma technology. Also offers phage library screening. From antigen design to purified antibody. Polyclonal success rate exceeds 99%.
- Bioinformatics Analysis Bioinformatics and statistical analysis services for genomics, transcriptomics, and proteomics data, providing expert guidance through all steps of data analysis from experiments.
- Clinical Trial Services for Celiac Disease Comprehensive services for celiac disease clinical trials including iVYDAL GIP detection products (stool and urine), clinical trial design, sample analysis and storage, final reports, and technical support.
Quantifiable outcome
- iVYLISA GIP Stool: 97.1% diagnostic sensitivity, 83.3% diagnostic specificity
- +6 more outcomes
Companies that use Biomedal
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Biomedal technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Biomedal partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- ICEX (Instituto de Comercio Exterior)coreBiomedal participates in the ICEX Next Program for international development of Spanish companies, receiving support and co-financing from the European FEDER fund to advance international expansion efforts.
- University of Seville (Universidad de Sevilla)coreJoint development and patenting of GIP detection technology using monoclonal antibodies G12 and A1. The collaboration between University of Seville and Biomedal SL resulted in proprietary technology for detecting Gluten Immunogenic Peptides in human samples for celiac disease monitoring.
- Federación de Asociaciones de Celíacos de España (FACE)coreBiomedal is a reference laboratory for FACE (Federation of Celiac Associations of Spain), providing allergen testing services and GIP detection validation for the celiac community in Spain.
- Asociación de Intolerantes a la Lactosa España (ADILAC)minorBiomedal holds reference laboratory status for ADILAC (Association of Lactose Intolerant Spain), providing lactose analysis services to support the lactose intolerance community.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Biomedal competitors and assessment
Company assessmentBroad incumbents
- SGS: Swiss-based global inspection, verification, testing and certification company with a substantial food and life sciences testing portfolio. Comparable to Biomedal's ISO 17025-accredited analytical services and life science offerings, particularly in allergen and microbiological testing.
- Eurofins Scientific: Global leader in food and pharmaceutical testing services, including allergen analysis, microbiological testing, and environmental analysis — directly comparable to Biomedal's Servicios Analíticos food testing division and life science services. Operates at vastly greater scale with global reach.
- Bio-Techne: Major life sciences tools company providing proteins, antibodies, ELISA kits, and diagnostics reagents. Comparable to Biomedal's antibody production and iVYDAL ELISA product lines; significantly larger and publicly listed with broader catalog.
- Inova Diagnostics (Werfen): Specialty diagnostics company (part of Werfen group) focused on autoimmune disease diagnostics, including celiac disease serology (anti-tTG, anti-endomysium). Comparable as a competitor in celiac disease diagnostic testing, though focused on serology rather than GIP detection.
- Prometheus Laboratories (Nestlé Health Science): Subsidiary of Nestlé Health Science historically focused on GI diagnostics including celiac disease serology and IBD. Comparable as a competitor in celiac disease monitoring, though Prometheus is now broader and Nestle-owned with significantly more distribution scale.
Direct peers
- GenScript: Global biotechnology company offering gene synthesis, peptide synthesis, antibody production, and protein expression services. Directly comparable to Biomedal's Life Science division across most of its service catalog (gene synthesis, peptide synthesis, antibody production, recombinant protein expression).
Regional players
- Grifols: Spanish-listed global healthcare company specializing in plasma-derived medicines and diagnostic systems. Comparable as a major Spanish-headquartered biotech/diagnostics company, though at much greater scale; useful benchmark for the Spanish biotech ecosystem and diagnostic commercialization pathways.
- PharmaMar: Spanish biotechnology company focused on oncology drug development, headquartered in Madrid. Comparable as a Spanish biotech of similar vintage and headcount scale, providing a regional benchmark for biotech operations in Spain, though operating in a different therapeutic area.
Emerging players
- Zedira: Specialty German biotech focused on transglutaminase and celiac disease research reagents, including diagnostic tools for celiac disease. Comparable as a niche player developing specialized celiac diagnostics, though Zedira's product focus is more research-grade than Biomedal's clinical/professional positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomedal social profiles
Digital presenceBiomedal compliance and trust
Trust signalCompliance5 records
Biomedal financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomedal leadership team
Management profileNumber of profiles
Profiles1 record
Biomedal funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomedal M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomedal
What does Biomedal do?
Biomedal is a biotechnology company that develops, manufactures, and commercializes in vitro diagnostic kits and laboratory services. Its flagship offering is the only non-invasive Gluten Immunogenic Peptides (GIP) detection technology for monitoring gluten-free diet adherence in celiac patients, using proprietary G12 and A1 monoclonal antibodies in ELISA and lateral flow formats. The company also operates ISO 17025-accredited food analytical laboratories and provides life science research services including gene synthesis, recombinant protein expression, peptide synthesis, and antibody production.
Is Biomedal a public or private company?
Biomedal is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biomedal founded?
Biomedal was founded in 2000. It employs 11 to 50 people.
Where is Biomedal based?
Biomedal is headquartered in Sevilla, Spain, in the Europe region.
How does Biomedal make money?
Three revenue lines are on record. In Vitro Diagnostic Products are the primary driver. The others are analytical Laboratory Services and life Science Research Services.
Who are Biomedal's main competitors?
Broad incumbents on record are SGS, Eurofins Scientific, Bio-Techne, Inova Diagnostics (Werfen) and Prometheus Laboratories (Nestlé Health Science). GenScript is listed as a direct peer. Regional players are Grifols and PharmaMar. Zedira is listed as an emerging player.
Does Biomedal have an API?
No public API is recorded for Biomedal.
What industry is Biomedal in?
Biomedal's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry), with a secondary code of HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support). Its NAICS code is 621511 and its SIC code is 2835.